If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,940.00    24.00 (0.82%)
Bid:
2,948.00
Ask:
2,952.00
Spread: 4.00 (0.136%)
Market Cap: £6.96b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Director/PDMR Shareholding

8 Jun 2023 15:18

RNS Number : 1558C
IMI PLC
08 June 2023
 

8 June 2023

 

IMI PLC(the "Company")

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Persons Closely Associated with them

The Company announces the following transaction by a PDMR in the Company's ordinary shares ("Shares"). Pursuant to invitations issued on 16 May 2023 to all eligible UK employees, options over an aggregate of 74,975 Shares were granted on 7 June 2023 under the IMI Sharesave Plan (the "Scheme"). The Scheme is an all-employee scheme which gives the opportunity to eligible UK employees to acquire Shares at a discount of 10% of the market value of the Shares at the time the invitation was issued. In consideration of these options, the grantees will make monthly savings during the associated savings contract. The exercise price is £14.5836 per share.

Options granted to a PDMR:

Name

Position

No. of shares under options granted

Savings Contract Period

Elizabeth Rose

Group HR Director

1,234

3 years

This notification relates to transactions notified in accordance with the Market Abuse Regulation, further details below:

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Elizabeth Rose

2.

Reason for the notification

a)

Position/status

Group HR Director

b)

Initial notification/ Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IMI plc

b)

LEI

2138002W9Q21PF751R30

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 28 4/7p each GB00BGLP8L22

b)

Nature of the transaction

Grant of options under the all-employee HMRC IMI Sharesave Plan.

 c)

Price(s) and volume(s)

Price(s)

Volume(s)

£14.5836

1,234

d)

Aggregated information

· Aggregated volume

· Price

N/A single transaction

e)

Date of the transaction

7 June 2023

f)

Place of the transaction

Outside of a trading venue

For further information, please contact:

 

Fran Burge

Assistant Company SecretaryTelephone: 0121 717 3700

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSWFLAEDSEFM
Date   Source Headline
3rd May 202210:01 amRNSTotal Voting Rights
21st Apr 202211:50 amRNSHolding(s) in Company
14th Apr 202212:16 pmRNSDirector/PDMR Shareholding
14th Apr 202212:15 pmRNSDirector/PDMR Shareholding
14th Apr 202212:12 pmRNSDirector/PDMR Shareholding
8th Apr 20223:18 pmRNSDirector/PDMR Shareholding
8th Apr 20223:15 pmRNSDirector/PDMR Shareholding
8th Apr 20223:07 pmRNSDirector/PDMR Shareholding
8th Apr 20223:00 pmRNSDirector/PDMR Shareholding
8th Apr 20222:53 pmRNSDirector/PDMR Shareholding
1st Apr 202210:39 amRNSTotal Voting Rights
31st Mar 20224:04 pmRNSDirector/PDMR Shareholding
31st Mar 20229:17 amRNSHolding(s) in Company
30th Mar 20226:03 pmRNSDirector/PDMR Shareholding
30th Mar 20226:02 pmRNSDirector/PDMR Shareholding
30th Mar 20225:58 pmRNSDirector/PDMR Shareholding
30th Mar 20225:57 pmRNSDirector/PDMR Shareholding
30th Mar 20225:53 pmRNSDirector/PDMR Shareholding
30th Mar 20225:49 pmRNSDirector/PDMR Shareholding
30th Mar 20225:48 pmRNSDirector/PDMR Shareholding
25th Mar 20224:21 pmRNSAnnual Financial Report
22nd Mar 20225:32 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:30 pmRNSDirector/PDMR Shareholding
9th Mar 20224:52 pmRNSDirector/PDMR Shareholding
9th Mar 20224:51 pmRNSDirector/PDMR Shareholding
9th Mar 20224:49 pmRNSDirector/PDMR Shareholding
8th Mar 20223:09 pmRNSHolding(s) in Company
7th Mar 20222:24 pmRNSDirector/PDMR Shareholding
1st Mar 20225:37 pmRNSDirector/PDMR Shareholding
1st Mar 202211:00 amRNSTotal Voting Rights
25th Feb 20227:00 amRNSPreliminary results, year ended 31 December 2021
10th Feb 202210:53 amRNSHolding(s) in Company
9th Feb 20225:20 pmRNSDirector/PDMR Shareholding
9th Feb 20225:19 pmRNSDirector/PDMR Shareholding
9th Feb 20225:15 pmRNSDirector/PDMR Shareholding
1st Feb 202211:25 amRNSTotal Voting Rights
25th Jan 20223:27 pmRNSHolding(s) in Company
12th Jan 20222:04 pmRNSDirector/PDMR Shareholding
12th Jan 20222:01 pmRNSDirector/PDMR Shareholding
12th Jan 20221:58 pmRNSDirector/PDMR Shareholding
12th Jan 20221:54 pmRNSDirector/PDMR Shareholding
4th Jan 20224:59 pmRNSBlock listing Interim Review
4th Jan 202211:55 amRNSTotal Voting Rights
20th Dec 20217:00 amRNSCompletion of Adaptas Solutions acquisition
15th Dec 20214:53 pmRNSDirector/PDMR Shareholding
15th Dec 20214:51 pmRNSDirector/PDMR Shareholding
15th Dec 20214:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.